Free Lipitor, Viagra, other drugs for jobless

May 14, 2009 By LINDA A. JOHNSON , AP Business Writer
FILE - In this Jan. 25, 2009 file photo, a bottle of Pfizer's Lipitor is shown in New York. Drugmaker Pfizer Inc. is unveiling a new program, Thursday, May 14, 2009, that will let people who have lost their jobs and health insurance keep taking their Pfizer medications _ for free, and for up to a year. (AP Photo/Mark Lennihan, file)

(AP) -- Pfizer Inc. is unveiling a new program Thursday that will let people who have lost their jobs and health insurance keep taking some widely prescribed Pfizer medications - including Lipitor and Viagra - for free for up to a year.

The world's biggest drugmaker will provide more than 70 of its at no cost to unemployed, uninsured Americans, regardless of their prior income, who lost jobs since Jan. 1 and have been on the Pfizer for three months or more.

The announcement comes amid massive job losses caused by the recession and a campaign in Washington to rein in costs and extend coverage. The move could earn Pfizer some goodwill in that debate after long being a target of critics of drug industry prices and sales practices.

The program also likely will help keep those patients loyal to Pfizer brands.

"Everybody knows now a neighbor, a relative who has lost their job and is losing their insurance. People are definitely hurting out there," Dr. Jorge Puente, Pfizer's head of pharmaceuticals outside the U.S. and Europe and a champion of the project, told The Associated Press in an exclusive interview Wednesday. "Our aim is to help people bridge this point."

Officials for New York-based Pfizer said they don't know how much the program will cost and haven't put a cap on spending for it.

Applicants will have to sign a statement that they are suffering financial hardship and provide a "pink slip" or similar employer notice. Applications will be accepted through Dec. 31, with medication provided for up to 12 months after approval - or until the person becomes insured again.

Starting Thursday, patients can call a toll-free number, 866-706-2400, to sign up, and those whose drugs are not included in the program will be referred to other company aid programs. Starting July 1, patients can also apply through the Web site, http://www.PfizerHelpfulAnswers.com , which has information about the other Pfizer aid programs.

Pfizer and the rest of the drug industry is trying to have a voice in the debate over how to overhaul the U.S. health care system, partly by joining in a pledge this week to help hold down inflation of health costs.

"There's a long-term benefit there, beyond the goodwill and the publicity," said David Heupel, health care portfolio manager at Thrivent Large Cap Growth Fund. "Pfizer is trying to maintain their (market) share, if not grow their share" by keeping people from switching to generic versions of its drugs to save money.

"If you're already taking medication that's working, typically doctors don't push to change it," Heupel said.

Pfizer's program comes at a time when many drugmakers, including Pfizer, have been raising prices on their drugs, partly to offset declines in revenue as the global reduces the number of prescriptions people can afford to fill.

The idea for the program came just five weeks ago, at a leadership training meeting, as the workers discussed how many patients are struggling, Puente said.

"It was my idea," he said. "I floated it, and the reception it got was so dramatic that it very quickly became our idea."

Colleagues suggested employees could donate to a fund to help support the effort, Puente said. He said some employees had tears in their eyes when discussing how they could help people who had lost jobs.

He said he urged top management to approve the program, presenting a recent Associated Press article about how newly uninsured diabetics are suffering serious complications because they can no longer afford the medicines and testing supplies. Approval came quickly.

The 70-plus drugs covered include several diabetes drugs and some of Pfizer's top money makers, from cholesterol fighter Lipitor and painkiller Celebrex to fibromyalgia treatment Lyrica and Viagra for impotence. The list includes drugs from several other popular classes, including antibiotics, antidepressants, antifungal treatments, several heart drugs, contraceptives and smoking cessation products. Cheaper generic versions are available for quite a few of the drugs.

Pfizer said that from 2004 through 2008, its patient assistance programs helped 5.1 million people get 51 million prescriptions for free or at reduced cost, with a total value of $4.8 billion.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: FDA approves hard-to-abuse narcotic painkiller

add to favorites email to friend print save as pdf

Related Stories

Pfizer drug found with serious side effect

Nov 01, 2006

U.S. pharmaceutical company Pfizer Inc. says clinical trials of its heart medication torcetrapib suggest the drug has a potentially serious side effect.

Viracept caution issued by Pfizer

Sep 10, 2007

Pfizer Inc. issued a "Dear Healhcare Professional" letter Monday warning of the presence of an impurity in its Viracept medication.

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

NIH scientist is under investigation

Jun 13, 2006

A U.S. House committee is reportedly investigating whether a senior government scientist improperly gave information to a pharmaceutical firm.

Mass. doctor accused of faking pain pill data

Mar 11, 2009

(AP) -- A Massachusetts anesthesiologist has been accused of faking data for a dozen years in 21 published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0